Symptomatic benefit of momelotinib in patients with myelofibrosis: Results from the SIMPLIFY phase III studies

Mesa, RA; Hudgens, S; Floden, L; Harrison, CN; Palmer, J; Gupta, V; McLornan, DP; McMullin, MF; Kiladjian, JJ; Foltz, L; Platzbecker, U; Fox, ML; Mead, AJ; Ross, DM; Oh, ST; Perkins, A; Leahy, MF; Deheshi, S; Donahue, R; Klencke, BJ; Verstovsek, S

Mesa, RA (通讯作者)，Wake Forest Univ, Atrium Hlth Wake Forest Baptist Comprehens Canc Ct, Sch Med, Med Ctr Blvd,11th Floor, Winston Salem, NC 27157 USA.

CANCER MEDICINE, 2023; 12 (9): 10612

Abstract

Background: Myelofibrosis (MF)-associated constitutional symptoms can severely impact health-related quality of life. Clinical trials in MF traditiona......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索